Introduction: In orthopedics, the use of rich plasma is still controversial, there is no consensus regarding its indications, and use, although its therapeutic usefulness for various conditions is proven, much remains to be studied on this promising topic. Purpose: With our study we intend to assess the clinical effectiveness and efficacy of the treatment imposed according to study groups. Method. A prospective pre-experimental study was carried out in adults with a diagnosis of orthopedic foot injuries, treated at the Orthopedics and Traumatology Service of the General University Hospital "Mártires del 9 de Abril", from January 2018 to December 2022, where the utility of the PRP is used and valued. Results Orthopedic foot injuries are more common in women between 41 and 60 years of age, 15.9% of the sample was treated with infiltration of platelet-rich plasma, pain decreased in all study groups, without However, the group where PRP infiltration is used represents the one with the best evolution of the patients seen in the clinic. Conclusions The results obtained in this study show that the treatment protocol applied is positive in each of the therapeutic options used from the point of view of pain improvement according to the visual analogue scale, highlighting the option of using PRP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.